share_log

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

4:持股變動聲明-股東 Nirland Ltd
美股SEC公告 ·  2024/10/02 17:05

Moomoo AI 已提取核心訊息

Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
作爲Conduit Pharmaceuticals (CDt.US)的股東,Nirland Ltd自2024年9月30日至2024年10月2日參與了一系列股票處置活動。這些交易涉及以每股價格從$0.1028到$0.12出售共計2,600,000股普通股。已處置股票的總市值約爲$297,644.36。在這些交易之後,Nirland Ltd對Conduit Pharmaceuticals的直接持股減少至9,900,000股。這些銷售是作爲公開市場交易或私人銷售進行的,並且目前仍在進行中。
作爲Conduit Pharmaceuticals (CDt.US)的股東,Nirland Ltd自2024年9月30日至2024年10月2日參與了一系列股票處置活動。這些交易涉及以每股價格從$0.1028到$0.12出售共計2,600,000股普通股。已處置股票的總市值約爲$297,644.36。在這些交易之後,Nirland Ltd對Conduit Pharmaceuticals的直接持股減少至9,900,000股。這些銷售是作爲公開市場交易或私人銷售進行的,並且目前仍在進行中。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息